Estrigenix is a new pharmaceutical company specializing in oestrogen biology.
Estrigenix Therapeutics has raised $2.0M in total funding. The most recent round was Seed. The last funding was announced in July 2026.
Estrigenix Therapeutics's investors include Talents Fund, Small Business Innovation Research, San Diego Angel Conference.
Estrigenix Therapeutics is headquartered in Milwaukee, United States.
Estrigenix is a new pharmaceutical company specializing in oestrogen biology.
Estrigenix Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Estrigenix Therapeutics — Funding & Investors." VCBacked, July 21, 2026, https://www.vcbacked.co/company/estrigenix-therapeutics. Accessed August 1, 2026.
VCBacked. (2026). Estrigenix Therapeutics — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/estrigenix-therapeutics
{{cite web |title=Estrigenix Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/estrigenix-therapeutics |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated